» Articles » PMID: 16293107

Computational Modelling of the Receptor-tyrosine-kinase-activated MAPK Pathway

Overview
Journal Biochem J
Specialty Biochemistry
Date 2005 Nov 19
PMID 16293107
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

The MAPK (mitogen-activated protein kinase) pathway is one of the most important and intensively studied signalling pathways. It is at the heart of a molecular-signalling network that governs the growth, proliferation, differentiation and survival of many, if not all, cell types. It is de-regulated in various diseases, ranging from cancer to immunological, inflammatory and degenerative syndromes, and thus represents an important drug target. Over recent years, the computational or mathematical modelling of biological systems has become increasingly valuable, and there is now a wide variety of mathematical models of the MAPK pathway which have led to some novel insights and predictions as to how this system functions. In the present review we give an overview of the processes involved in modelling a biological system using the popular approach of ordinary differential equations. Focusing on the MAPK pathway, we introduce the features and functions of the pathway itself before comparing the available models and describing what new biological insights they have led to.

Citing Articles

Unraveling the Anti-Cancer Mechanisms of Antibiotics: Current Insights, Controversies, and Future Perspectives.

Karamanolis N, Kounatidis D, Vallianou N, Dimitriou K, Tsaroucha E, Tsioulos G Antibiotics (Basel). 2025; 14(1).

PMID: 39858295 PMC: 11762948. DOI: 10.3390/antibiotics14010009.


Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.

Jeon S, Jeon Y, Lim J, Kim Y, Cha B, Kim W Signal Transduct Target Ther. 2025; 10(1):4.

PMID: 39757214 PMC: 11701242. DOI: 10.1038/s41392-024-02070-1.


PCA-based synthetic sensitivity coefficients for chemical reaction network in cancer.

Biddau G, Caviglia G, Piana M, Sommariva S Sci Rep. 2024; 14(1):17706.

PMID: 39085332 PMC: 11291660. DOI: 10.1038/s41598-024-67862-5.


Simulating BRAFV600E-MEK-ERK signalling dynamics in response to vertical inhibition treatment strategies.

De Carli A, Kapelyukh Y, Kursawe J, Chaplain M, Wolf C, Hamis S NPJ Syst Biol Appl. 2024; 10(1):51.

PMID: 38750040 PMC: 11096323. DOI: 10.1038/s41540-024-00379-9.


The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity.

Sikiric P, Boban Blagaic A, Strbe S, Beketic Oreskovic L, Oreskovic I, Sikiric S Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675421 PMC: 11053547. DOI: 10.3390/ph17040461.


References
1.
Swain P, Siggia E . The role of proofreading in signal transduction specificity. Biophys J. 2002; 82(6):2928-33. PMC: 1302080. DOI: 10.1016/S0006-3495(02)75633-6. View

2.
Dhillon A, Kolch W . Untying the regulation of the Raf-1 kinase. Arch Biochem Biophys. 2002; 404(1):3-9. DOI: 10.1016/s0003-9861(02)00244-8. View

3.
Bhalla U, Ram P, Iyengar R . MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science. 2002; 297(5583):1018-23. DOI: 10.1126/science.1068873. View

4.
Kitano H . Biological robustness. Nat Rev Genet. 2004; 5(11):826-37. DOI: 10.1038/nrg1471. View

5.
Kurnaz I . Kinetic analysis of RSK2 and Elk-1 interaction on the serum response element and implications for cellular engineering. Biotechnol Bioeng. 2004; 88(7):890-900. DOI: 10.1002/bit.20322. View